Oryx Ventures
VC Fund
Dubai, United Arab Emirates
Oryx Ventures is a venture capital firm that focuses on investing in growth stage technology companies based out of the USA.
- Total investments:
- 10
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Oryx Ventures invests in
Enterprise SoftwareArtificial IntelligenceAnalyticsData CenterBiotechnology
Stages Oryx Ventures invests in
Series BSeries CSeries ASeries ESeries F
Countries Oryx Ventures invests in
United StatesIsle of ManUnited Kingdom
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Investment Focus
Industry
- Enterprise Software 3 (30%)
- Artificial Intelligence 3 (30%)
- Analytics 2 (20%)
- Data Center 2 (20%)
- Biotechnology 2 (20%)
Stage
- Series B 3 (30%)
- Series C 2 (20%)
- Series A 1 (10%)
- Series E 1 (10%)
- Series F 1 (10%)
Country
- United States 5 (50%)
- Isle of Man 1 (10%)
- United Kingdom 1 (10%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Abdulaziz Sagha
Founder & Managing Partner
|
Founder & Managing Partner | Total investments: 4 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Omneky
|
Omneky is an AI-agentic advertising platform that generates and orchestrates personalized omni-channel ad campaigns. By analyzing cross-channel marketing data from platforms like Meta, Google, TikTok, Reddit and LinkedIn, Omneky identifies the specific design elements and messaging that drive conversions. It then leverages generative AI to quicklyproduce and launch highly tailored image and video ads across various advertising channels, helping brands optimize their campaigns, reduce creative fatigue, and ultimately increase return on ad spend. | Venture - Series Unknown / Jan 20, 2026 | |
Beckley Psytech
|
Beckley Psytech operates as a psychedelic medicine company. The company is involved in exploring the therapeutic potential of psychedelic substances, such as psilocybin and other compounds, for mental health treatment. The company envisions the integration of clinically validated psychedelic medicines into contemporary medical practices to assistindividuals coping with depression and other significantly debilitating neuropsychiatric conditions characterized by a substantial unmet need. | $80.4M / Series B / Aug 15, 2021 | |
DataRobot
|
DataRobot delivers AI technology and ROI enablement services to global enterprises competing in today’s intelligence revolution. DataRobot’s enterprise AI platform democratizes data science with end-to-end automation for building, deploying, and managing machine learning models.The company was founded in 2012 and is headquartered in Boston,Massachusetts. | $270M / Series F / Nov 17, 2020 | |
|
Beckley Psytech
|
Beckley Psytech operates as a psychedelic medicine company. The company is involved in exploring the therapeutic potential of psychedelic substances, such as psilocybin and other compounds, for mental health treatment. The company envisions the integration of clinically validated psychedelic medicines into contemporary medical practices to assistindividuals coping with depression and other significantly debilitating neuropsychiatric conditions characterized by a substantial unmet need. | $14.9M / Series A / Jun 30, 2020 | |
|
DataRobot
|
DataRobot delivers AI technology and ROI enablement services to global enterprises competing in today’s intelligence revolution. DataRobot’s enterprise AI platform democratizes data science with end-to-end automation for building, deploying, and managing machine learning models.The company was founded in 2012 and is headquartered in Boston,Massachusetts. | $206M / Series E / Sep 17, 2019 | |
Juvenescence
|
Juvenescence Limited is a British Virgin Islands-based holding company that invests in human aging and longevity. Juvenescence has raised $111M to build an ecosystem and pipeline of assets targeting aging, age-related disease, and regeneration. Juvenescence believes that recent scientific and medical advances will enable the development oftherapeutics that meaningfully extend human healthspan and eventually lifespan. A meaningful increase in lifespan in the already aging world will have profound implications on all sectors of society, and in particular healthcare, education, insurance, and leisure.The company creates and partners with new companies with longevity-related therapeutics, by in-licensing compounds from academia and industry, or forming joint ventures with the foremost longevity scientists and leading research institutions. Their work is based on a novel scientific understanding of the underlying biological causes of aging, to create evidence-based therapeutics that can treat diseases of aging.Juvenescence's goal is to extend both lifespan and healthspan, by developing therapeutics that slow aging and promote juvenescence. | $100M / Series B / Aug 19, 2019 | |
Cohesity
|
Cohesity is a data management technology company that provides hyper-converged secondary storage solutions for backups, file services, and analytics. With the Cohesity Data Cloud, organizations can secure, manage, and recover data at an enterprise scale while gaining insights through AI capabilities. | $90M / Series C / Apr 04, 2017 | |
Versa Networks
|
Versa Networks, the leader in SASE, combines extensive security, advanced networking, full-featured SD-WAN, genuine multitenancy, and sophisticated analytics via the cloud, on-premises, or as a blended combination of both to meet SASE requirements for small to extremely large enterprises and Service Providers. Versa SASE is available on-premises,hosted through Versa-powered Service Providers, cloud-delivered, and via the simplified Versa Titan cloud service designed for Lean IT. Thousands of customers globally with hundreds of thousands of sites trust Versa with their networks, security, and clouds. Versa Networks is privately held and funded by Sequoia Capital, Mayfield, Artis Ventures, Verizon Ventures, Comcast Ventures, Liberty Global Ventures, Princeville Global Fund and RPS Ventures. | $36M / Series C / Dec 23, 2016 | |
|
Cohesity
|
Cohesity is a data management technology company that provides hyper-converged secondary storage solutions for backups, file services, and analytics. With the Cohesity Data Cloud, organizations can secure, manage, and recover data at an enterprise scale while gaining insights through AI capabilities. | $55M / Series B / Jun 17, 2015 | |
Palantir Technologies
|
Palantir Technologies offers a suite of software applications for integrating, visualizing, and analyzing information. Palantir software allows analysts within and between government organizations to collaborate and analyze large quantities of data. Palantir Technologies was founded in 2004 and is headquartered in Denver, Colorado. | Secondary Market / Jan 01, 2015 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
SaaS Investors
99,274 investors
Enterprise Investors
77,348 investors
Artificial intelligence Investors
40,702 investors
Hardware Investors
40,144 investors
Biotech Investors
21,775 investors
Biotechnology Investors
19,370 investors
Enterprise Software Investors
13,836 investors
SaaS VC Funds
61,208 investors
Enterprise VC Funds
49,693 investors
FAQ
What does Oryx Ventures invest in?
Oryx Ventures invests primarily in Enterprise Software, Artificial Intelligence and Analytics startups, most often at Series B and Series C stage. Most of the 10 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Oryx Ventures?
Public channels for Oryx Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Oryx Ventures?
The team at Oryx Ventures includes Abdulaziz Sagha (Founder & Managing Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
